 The court's decision is the latest setback for Giuliani, who is facing bankruptcy after being ordered to pay some $150 million for defaming two former election workers. Ryan Lucas, NPR News, Washington. A new drug for people with early Alzheimer's disease will soon be available in the U.S. NPR's Sidney Lumpkin has more on the medicine that can slow the course of the illness. The Food and Drug Administration approved Casunla, an Alzheimer's drug made by Eli Lilly. Casunla isn't a cure, but it slowed patients' cognitive decline in clinical trials.